Dianthus Therapeutics Stock Price on February 8, 2024
| DNTH Stock | 20.70 1.46 6.59% |
Below is the normalized historical share price chart for Dianthus Therapeutics extending back to June 21, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Dianthus Therapeutics stands at 20.70, as last reported on the 31st of May, with the highest price reaching 20.70 and the lowest price hitting 20.70 during the day.
If you're considering investing in Dianthus Stock, it is important to understand the factors that can impact its price. Dianthus Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0404, which denotes the company had a -0.0404% return per unit of standard deviation over the last 3 months. Dianthus Therapeutics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Dianthus Therapeutics' Mean Deviation of 3.79, coefficient of variation of (2,620), and Standard Deviation of 5.05 to check the risk estimate we provide.
As of now, Dianthus Therapeutics' Stock Based Compensation is increasing as compared to previous years. The Dianthus Therapeutics' current Stock Based Compensation To Revenue is estimated to increase to 1.08, while Liabilities And Stockholders Equity is projected to decrease to under 112.5 M. . The Dianthus Therapeutics' current Price Earnings To Growth Ratio is estimated to increase to 0.02, while Price To Sales Ratio is projected to decrease to 18.02. Dianthus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of September 2023 | 200 Day MA 6.0253 | 50 Day MA 11.4072 |
Dianthus |
Sharpe Ratio = -0.0404
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DNTH |
Estimated Market Risk
| 5.12 actual daily | 45 55% of assets are more volatile |
Expected Return
| -0.21 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Dianthus Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dianthus Therapeutics by adding Dianthus Therapeutics to a well-diversified portfolio.
Price Book 2.9387 | Enterprise Value Ebitda (7.35) | Price Sales 147.9146 | Shares Float 4.4 M | Wall Street Target Price 28.5 |
Dianthus Therapeutics Valuation on February 8, 2024
It is possible to determine the worth of Dianthus Therapeutics on a given historical date. On February 8, 2024 Dianthus was worth 24.0 at the beginning of the trading date compared to the closed value of 23.2. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Dianthus Therapeutics stock. Still, in general, we apply an absolute valuation method to find Dianthus Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Dianthus Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Dianthus Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 22.32 | 24.44 | 21.25 | 24.20 | 267,034 | |
02/08/2024 | 24.00 | 25.16 | 20.75 | 23.20 | 210,582 |
| 22.95 | 24.25 | 21.85 | 23.94 | 204,298 |
| Backtest Dianthus Therapeutics | | | Dianthus Therapeutics History | | | Dianthus Therapeutics Valuation | Previous | Next |
Dianthus Therapeutics Trading Date Momentum on February 8, 2024
| On February 09 2024 Dianthus Therapeutics was traded for 23.94 at the closing time. The top price for the day was 24.25 and the lowest listed price was 21.85 . The trading volume for the day was 204.3 K. The trading history from February 9, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 3.19% . The overall trading delta against the current closing price is 3.45% . |
Dianthus Therapeutics Fundamentals Correlations and Trends
By evaluating Dianthus Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Dianthus Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Dianthus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Dianthus Therapeutics Stock history
Dianthus Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Dianthus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Dianthus Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Dianthus Therapeutics stock prices may prove useful in developing a viable investing in Dianthus Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 5.2 M | 7.2 M | |
| Net Loss | -25.6 M | -26.9 M |
Dianthus Therapeutics Quarterly Net Working Capital |
|
Dianthus Therapeutics Stock Technical Analysis
Dianthus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Dianthus Therapeutics Period Price Range
Low | February 8, 2024
| High |
24.00 | 23.20 |
Dianthus Therapeutics May 31, 2024 Market Strength
Market strength indicators help investors to evaluate how Dianthus Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dianthus Therapeutics shares will generate the highest return on investment. By undertsting and applying Dianthus Therapeutics stock market strength indicators, traders can identify Dianthus Therapeutics entry and exit signals to maximize returns
| Accumulation Distribution | 36910.44 | |||
| Daily Balance Of Power | (0.18) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 22.96 | |||
| Day Typical Price | 23.04 | |||
| Price Action Indicator | (0.16) | |||
| Period Momentum Indicator | (2.50) |
Dianthus Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Dianthus Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Dianthus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Dianthus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.32) | |||
| Treynor Ratio | (0.11) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dianthus Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Dianthus Stock please use our How to Invest in Dianthus Therapeutics guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Dianthus Stock analysis
When running Dianthus Therapeutics' price analysis, check to measure Dianthus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dianthus Therapeutics is operating at the current time. Most of Dianthus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dianthus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dianthus Therapeutics' price. Additionally, you may evaluate how the addition of Dianthus Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is Dianthus Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dianthus Therapeutics. If investors know Dianthus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dianthus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.91) | Revenue Per Share 0.742 | Quarterly Revenue Growth (0.21) |
The market value of Dianthus Therapeutics is measured differently than its book value, which is the value of Dianthus that is recorded on the company's balance sheet. Investors also form their own opinion of Dianthus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dianthus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dianthus Therapeutics' market value can be influenced by many factors that don't directly affect Dianthus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dianthus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dianthus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dianthus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.